Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Cytokinetics: Update based on 2Q, 2018 Conference Call (CYTK, Buy, $6.85)

Investment Thesis

Omecamtiv is the Essence of the Investment Thesis

I continue to believe that Cytokinetics is an attractive investment based…
Read more…